Product
13-valent Pneumococcal Polysaccharide Conjugate Vaccine
1 clinical trial
1 indication
Indication
Pneumococcal InfectionsClinical trial
An Open-label Combined Randomized Double-blind, Positive Control Clinical Trial in Subjects Aged 2 Months (Minimum 6 Weeks) and Above to Preliminary Evaluate the Safety and Immunogenicity of a 13-valent Pneumococcal Polysaccharide Conjugate VaccineStatus: Recruiting, Estimated PCD: 2023-12-30